Literature DB >> 26276374

Beyond Candida albicans: Mechanisms of immunity to non-albicans Candida species.

Natasha Whibley1, Sarah L Gaffen2.   

Abstract

The fungal genus Candida encompasses numerous species that inhabit a variety of hosts, either as commensal microbes and/or pathogens. Candida species are a major cause of fungal infections, yet to date there are no vaccines against Candida or indeed any other fungal pathogen. Our knowledge of immunity to Candida mainly comes from studies on Candida albicans, the most frequent species associated with disease. However, non-albicans Candida (NAC) species also cause disease and their prevalence is increasing. Although research into immunity to NAC species is still at an early stage, it is becoming apparent that immunity to C. albicans differs in important ways from non-albicans species, with important implications for treatment, therapy and predicted demographic susceptibility. This review will discuss the current understanding of immunity to NAC species in the context of immunity to C. albicans, and highlight as-yet unanswered questions.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Candida albicans; Fungal immunity; Non-albicans species

Mesh:

Year:  2015        PMID: 26276374      PMCID: PMC4573358          DOI: 10.1016/j.cyto.2015.07.025

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  175 in total

1.  The epidemiology of hematogenous candidiasis caused by different Candida species.

Authors:  D Abi-Said; E Anaissie; O Uzun; I Raad; H Pinzcowski; S Vartivarian
Journal:  Clin Infect Dis       Date:  1997-06       Impact factor: 9.079

2.  Candida glabrata intra-abdominal candidiasis is characterized by persistence within the peritoneal cavity and abscesses.

Authors:  Shaoji Cheng; Cornelius J Clancy; Douglas J Hartman; Binghua Hao; M Hong Nguyen
Journal:  Infect Immun       Date:  2014-05-05       Impact factor: 3.441

3.  Candida albicans triggers interleukin-8 secretion by oral epithelial cells.

Authors:  A Dongari-Bagtzoglou; H Kashleva
Journal:  Microb Pathog       Date:  2003-04       Impact factor: 3.738

4.  Efficacies of fluconazole, caspofungin, and amphotericin B in Candida glabrata-infected p47phox-/- knockout mice.

Authors:  Justina Y Ju; Cynthia Polhamus; Kieren A Marr; Steven M Holland; John E Bennett
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

5.  Neutrophil depletion increases susceptibility to systemic and vaginal candidiasis in mice, and reveals differences between brain and kidney in mechanisms of host resistance.

Authors:  A Fulurija; R B Ashman; J M Papadimitriou
Journal:  Microbiology       Date:  1996-12       Impact factor: 2.777

6.  Candida albicans Hyr1p confers resistance to neutrophil killing and is a potential vaccine target.

Authors:  Guanpingsheng Luo; Ashraf S Ibrahim; Brad Spellberg; Clarissa J Nobile; Aaron P Mitchell; Yue Fu
Journal:  J Infect Dis       Date:  2010-06-01       Impact factor: 5.226

7.  Elimination of mouse splenic macrophages correlates with increased susceptibility to experimental disseminated candidiasis.

Authors:  Q Qian; M A Jutila; N Van Rooijen; J E Cutler
Journal:  J Immunol       Date:  1994-05-15       Impact factor: 5.422

8.  Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells.

Authors:  Eva V Acosta-Rodriguez; Laura Rivino; Jens Geginat; David Jarrossay; Marco Gattorno; Antonio Lanzavecchia; Federica Sallusto; Giorgio Napolitani
Journal:  Nat Immunol       Date:  2007-05-07       Impact factor: 25.606

Review 9.  Candida and candidiasis: the cell wall as a potential molecular target for antifungal therapy.

Authors:  Daniel Gozalbo; Patricia Roig; Eva Villamón; María Luisa Gil
Journal:  Curr Drug Targets Infect Disord       Date:  2004-06

10.  Activity of novel non-amphipathic cationic antimicrobial peptides against Candida species.

Authors:  Lori L Burrows; Margareta Stark; Celine Chan; Evgenia Glukhov; Selva Sinnadurai; Charles M Deber
Journal:  J Antimicrob Chemother       Date:  2006-03-08       Impact factor: 5.790

View more
  9 in total

1.  Vaccination with Secreted Aspartyl Proteinase 2 Protein from Candida parapsilosis Can Enhance Survival of Mice during C. tropicalis-Mediated Systemic Candidiasis.

Authors:  Manisha Shukla; Soma Rohatgi
Journal:  Infect Immun       Date:  2020-09-18       Impact factor: 3.441

Review 2.  A chronic hemodialysis patient with isolated pulmonary valve infective endocarditis caused by non-albicans Candida: a rare case and literature review.

Authors:  Chih-Hao Chang; Myo-Ming Huang; Dong-Feng Yeih; Kuo-Cheng Lu; Yi-Chou Hou
Journal:  BMC Nephrol       Date:  2017-09-06       Impact factor: 2.388

Review 3.  Lactoferrin, chitosan and Melaleuca alternifolia-natural products that show promise in candidiasis treatment.

Authors:  Lorena de Oliveira Felipe; Willer Ferreira da Silva Júnior; Katialaine Corrêa de Araújo; Daniela Leite Fabrino
Journal:  Braz J Microbiol       Date:  2017-11-11       Impact factor: 2.476

4.  New Benzimidazole-1,2,4-Triazole Hybrid Compounds: Synthesis, Anticandidal Activity and Cytotoxicity Evaluation.

Authors:  Hülya Karaca Gençer; Ulviye Acar Çevik; Serkan Levent; Begüm Nurpelin Sağlık; Büşra Korkut; Yusuf Özkay; Sinem Ilgın; Yusuf Öztürk
Journal:  Molecules       Date:  2017-03-27       Impact factor: 4.411

5.  Intravital Imaging Reveals Divergent Cytokine and Cellular Immune Responses to Candida albicans and Candida parapsilosis.

Authors:  Linda S Archambault; Dominika Trzilova; Sara Gonia; Cheryl Gale; Robert T Wheeler
Journal:  mBio       Date:  2019-05-14       Impact factor: 7.867

Review 6.  The role of Lactobacillus species in the control of Candida via biotrophic interactions.

Authors:  Isabella Zangl; Ildiko-Julia Pap; Christoph Aspöck; Christoph Schüller
Journal:  Microb Cell       Date:  2019-11-25

7.  A new humanized antibody is effective against pathogenic fungi in vitro.

Authors:  Tomas Di Mambro; Tania Vanzolini; Pierpaolo Bruscolini; Sergio Perez-Gaviro; Emanuele Marra; Giuseppe Roscilli; Marzia Bianchi; Alessandra Fraternale; Giuditta Fiorella Schiavano; Barbara Canonico; Mauro Magnani
Journal:  Sci Rep       Date:  2021-09-30       Impact factor: 4.379

Review 8.  The Role of IL-17 in Protection against Mucosal Candida Infections.

Authors:  Bemnet G Mengesha; Heather R Conti
Journal:  J Fungi (Basel)       Date:  2017-09-27

9.  Candida albicans enhances meropenem tolerance of Pseudomonas aeruginosa in a dual-species biofilm.

Authors:  Farhana Alam; Dominic Catlow; Alessandro Di Maio; Jessica M A Blair; Rebecca A Hall
Journal:  J Antimicrob Chemother       Date:  2020-04-01       Impact factor: 5.790

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.